Skip to main content
GLSI logo

GLSI · Greenwich LifeSciences, Inc.

$14.02 +1.22 (+9.53%) At close · Jul 30
Market Cap
$205.79M
Shares
14.68M

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-07-14 1,163 $18.57 $21,597
2026-07-10 4,544 $19.57 $88,926
2026-07-09 976 $18.87 $18,417
2026-07-08 856 $18.57 $15,896
2026-07-07 512 $20.44 $10,465
2026-07-06 100 $22.00 $2,200
2026-07-02 12,303 $23.70 $291,581
2026-07-01 2,129 $23.46 $49,946
2026-06-30 2 $23.25 $47
2026-06-29 17,833 $19.80 $353,093
2026-06-26 49,137 $18.33 $900,681
2026-06-25 7,347 $21.53 $158,181
2026-06-24 12,134 $23.03 $279,446
2026-06-23 8,779 $23.75 $208,501
2026-06-22 5,326 $23.38 $124,522
2026-06-18 401 $23.99 $9,620
2026-06-17 175 $23.88 $4,179
2026-06-16 6,162 $23.41 $144,252
2026-06-15 5,768 $24.06 $138,778
2026-06-10 45,842 $22.23 $1,019,068
2026-06-09 44,337 $21.65 $959,896
2026-06-08 27,482 $22.25 $611,475
2026-06-05 168 $23.67 $3,977
2026-06-04 10,313 $24.29 $250,503
2026-06-03 15,937 $24.29 $387,110
2026-06-02 2,812 $28.51 $80,170
2026-06-01 3,118 $26.18 $81,629
2026-05-29 23,694 $28.99 $686,889
2026-05-28 25,915 $29.23 $757,495
2026-05-27 3,861 $27.39 $105,753
2026-05-26 366 $27.65 $10,120
2026-05-22 164 $27.19 $4,459
2026-05-20 1,783 $26.31 $46,911
2026-05-19 6,848 $26.88 $184,074
2026-05-18 6,744 $27.21 $183,504
2026-05-15 6,628 $25.97 $172,129
2026-05-14 19,341 $25.30 $489,327
2026-05-13 42,840 $24.71 $1,058,576
2026-05-12 64,234 $24.13 $1,549,966
2026-05-11 4,092 $22.86 $93,543
2026-05-08 9,635 $23.62 $227,579
2026-05-07 7,197 $23.06 $165,963
2026-05-06 1,879 $22.30 $41,902
2026-05-05 559 $21.98 $12,287
2026-05-04 3,843 $23.70 $91,079
2026-05-01 5,494 $23.62 $129,768
2026-04-30 12,510 $21.60 $270,216
Showing 1–47 of 47 settlements
Key facts CIK 1799788 CUSIP 396879108 13F (30d) 10 filings 10 filers Visit website Investor relations